Oxidative Stress Is Differentially Present in Multiple Sclerosis Courses, Early Evident, and Unrelated to Treatment

Figure 1

Bar plot showing mean values, and bars represent SD. (a) CoQ₁₀ levels in healthy controls (HC) and multiple sclerosis patients (MS), 𝑃=0.001; (b) CoQ₁₀ levels in HC, primary progressive (PP), secondary progressive (SP), relapsing-remitting (RR), and benign (BB) MS, 𝑃<0.05; (c) CoQ₁₀ in HC and MS stratified for age (49 years: median age), ^∗𝑃=0.005; (d) anti-oxLDL levels in HC and MS, 𝑃=0.038; (e) anti-oxLDL levels in HC, PP, SP, RR, and BB, 𝑃=0.013; (f) anti-oxLDL levels in HC and MS stratified for age, 𝑃=0.024.

(a)

(b)

(c)

(d)

(e)

(f)